In July 2026, a significant supply bottleneck hit the generic behavioral health market as a widespread wave of Class II recalls severely impacted the availability of generic Cymbalta. With major generic manufacturers like Ajanta facing massive market withdrawals due to nitrosamine impurities detected during long-term stability testing, independent pharmacies are under immediate procurement pressure. If … Read more
In July 2026, a major disruption hit the ophthalmic prescription market when Lupin initiated a Class II recall for its Prednisolone Acetate Ophthalmic Suspension, USP, 1%. With over 2.5 million bottles pulled from the market due to the potential presence of a foreign substance, independent pharmacies may be facing immediate replacement stock pressure. If your … Read more
If you run an independent pharmacy, you already know the sinking feeling of logging into your primary wholesaler portal, typing in an NDC for a critical hormone replacement therapy, and seeing that dreaded red text. Allocated or Out of Stock. Right now, the surge in demand for menopausal treatments has created severe bottlenecks in the … Read more
Pharmacy leaders are juggling tighter margins, supply volatility, and rising compliance expectations. DSCSA and EPCIS sit at the center of that reality in 2025. Recently named one of Dispense Marketing’s Top 10 Secondary Pharmaceutical Wholesalers for 2025, Republic Pharmaceuticals has implemented EPCIS-based data exchange and end-to-end documentation so independent pharmacies can buy with confidence. Quick … Read more
Physician practices across the U.S. are feeling the squeeze. Rising drug costs, shrinking reimbursements, and unpredictable supply chains have made it harder than ever to keep essential medications in stock—without breaking the budget. That’s why finding reliable wholesale medications for physicians has become a top priority for clinics, urgent care centers, physician dispensers, and private … Read more
Primary wholesalers aren’t built for flexibility. In 2025, with Medicaid reimbursement changes, new CMS reporting rules, and the rising cost of generics, independent pharmacies are facing mounting pressure. That’s why more pharmacy owners are turning to secondary pharmaceutical wholesalers like Republic Pharmaceuticals — for better pricing, faster response times, and contract-free buying. 1. The Big … Read more
California’s independent pharmacies are under pressure — shrinking margins, rising acquisition costs, and inconsistent reimbursement make it harder than ever to stay competitive. That’s why Republic Pharmaceuticals is offering a solution built for California: Ibuprofen 300 mg Tablets (NDC: 70512-0794-90), a limited-distribution NSAID with high AWP, strong margins, and protection from marketplace price erosion. Why … Read more
LidoPro Patch for workers’ comp is quickly becoming the go-to option for New York pharmacies looking to offer effective, non-opioid pain relief. Big wholesalers don’t carry it, the margins are tight, and patients still need results—fast. That’s where LidoPro Patch comes in. LidoPro offers pharmacies a way to deliver high-quality, non-opioid pain relief to workers’ … Read more
The One Big Beautiful Bill (OBBB) has been signed into law. News coverage is focused on the political headlines, but for pharmacy owners, the real question is: What does this mean for my business? If you’re curious how these changes affect patients—especially seniors—check out this guide for seniors on how the Big Beautiful Bill impacts … Read more
How Republic Helps Independent Pharmacies Compete and Save A trusted secondary pharmaceutical wholesaler can be a game-changer for independent pharmacies. While primary wholesalers—often referred to as the “Big 3″—dominate the pharmaceutical supply chain, they often come with strings attached: contracts, rebate games, strict allocations, and inflexible payment terms. That’s where Republic Pharmaceuticals steps in—offering flexibility, … Read more